Project documents | Nivolumab with ipilimumab for untreated non-small-cell lung cancer that has a high tumour mutational burden [ID1187] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 266 KB)

Published:

12 June 2018
Final matrix (MSWord 76 KB)

Published:

12 June 2018
Equality impact assessment (Scoping) (PDF 172 KB)

Published:

12 June 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (MSWord 36 KB)

Published:

01 May 2018
Draft matrix post referral (MSWord 75 KB)

Published:

01 May 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 357 KB)

Published:

18 September 2017
Draft matrix post referral (PDF 338 KB)

Published:

18 September 2017